Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.47 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.45 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.43 |
| ▸ | HTR3B | O95264 | 2/20 | 0.43 |
| ▸ | HTR3A | P46098 | 2/20 | 0.43 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.43 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12692038 | 0.92 | POLB (0.40) | CHRM2CHRM4CHRM1CHRM3CHRNA7 | |
| SCHEMBL2839505 | 0.91 | SCN1A (0.47) | CHRM2CHRM4CHRM1CHRM3CHRNA7 | |
| SCHEMBL2896530 | 0.87 | KMO (0.43) | CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL2898584 | 0.83 | BCHE (0.45) | BCHE | |
| SCHEMBL2899217 | 0.83 | SCN1A (0.49) | — | |
| SCHEMBL4401228 | 0.81 | KMT2A (0.40) | — | |
| SCHEMBL6475721 | 0.81 | SRD5A2 (0.40) | CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL14002248 | 0.79 | MEN1 (0.43) | CHRM2CHRM4CHRM1CHRM3BCHE | |
| SCHEMBL6481509 | 0.79 | SRD5A2 (0.45) | — | |
| SCHEMBL2896264 | 0.79 | SRD5A2 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS, PBC | 2025-10-09 | — | — | US | disclosed |
| EP-2094760-B1 | COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD | 3M INNOVATIVE PROPERTIES CO (US) | 2017-05-31 | — | — | EP | disclosed |
| EP-1884519-B1 | METAL HYDRIDE COMPLEX, METHOD OF HYDROGENATING RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN, AND PROCESS FOR PRODUCING PRODUCT OF HYDROGENATION OF RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | JSR CORP (JP) | 2014-03-19 | — | — | EP | disclosed |
| US-8431625-B2 | Compositions curable by ring opening metathesis polymerization at low temperatures and their application in the dental field | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-04-30 | — | — | US | disclosed |
| US-8431625-B2 | Compositions curable by ring opening metathesis polymerization at low temperatures and their application in the dental field | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-04-30 | — | — | US | disclosed |
| US-8178604-B2 | Solid materials obtainable by ring-opening metathesis polymerization | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-05-15 | — | — | US | disclosed |
| US-8178604-B2 | Solid materials obtainable by ring-opening metathesis polymerization | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-05-15 | — | — | US | disclosed |
| EP-1815838-B1 | Solid materials obtainable by the ring-opening methathesis polymerization | 3M INNOVATIVE PROPERTIES CO (US) | 2010-09-08 | — | — | EP | disclosed |
| US-7675587-B2 | Polarizing plate and process for producing the same | JSR CORPORATION (JP) | 2010-03-09 | — | — | US | disclosed |
| US-20100036015-A1 | COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD | 3M INNOVATIVE PROPERTIES COMPANY | 2010-02-11 | — | — | US | disclosed |
| EP-1884519-A1 | METAL HYDRIDE COMPLEX, METHOD OF HYDROGENATING RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN, AND PROCESS FOR PRODUCING PRODUCT OF HYDROGENATION OF RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | JSR Corporation (JP) | 2008-02-06 | — | — | EP | disclosed |
| US-20070182895-A1 | Liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| WO-2007089801-A1 | SOLID MATERIALS OBTAINABLE BY RING-OPENING METATHESIS POLYMERIZATION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-08-09 | — | — | WO | disclosed |
| EP-1815838-A1 | Solid materials obtainable by the ring-opening methathesis polymerization | 3M Innovative Properties Company (US) | 2007-08-08 | — | — | EP | disclosed |
| US-7101498-B2 | Thermoplastic norbornene resin based optical film | JSR CORPORATION (JP) | 2006-09-05 | — | — | US | disclosed |
| EP-1626294-A2 | Polarizing plate and process for producing the same | JSR Corporation (JP) | 2006-02-15 | — | — | EP | disclosed |
| US-20060027322-A1 | Polarizing plate and process for producing the same | JSR CORPORATION (JP) | 2006-02-09 | — | — | US | disclosed |
| US-20040242823-A1 | Thermoplastic norbornene resin based optical film | JSR CORPORATION (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-1459107-A2 | THERMOPLASTIC NORBORNENE RESIN BASED OPTICAL FILM | JSR Corporation (JP) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003056365-A2 | THERMOPLASTIC NORBORNENE RESIN BASED OPTICAL FILM | JSR CORPORATION (JP) | 2003-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CYP8B1, CYP1B1, BBOX1 | CHRM2 3001/4885CHRM4 3652/4885CHRM1 2336/4885 |
| US-20100036015-A1 | COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD | DNMT3B, HMBS, MMAB | CHRM2 2124/4885CHRM4 1660/4885CHRM1 1075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.